CI

At a glance

ClinicalIndex Comparison Record
Phase 3Recruiting· 1,218 target
Drug / intervention
direct IV injection +1 moredrug
Likely dose
direct IV injection 2 mg/kgfrom record
Key inclusion· 10
  • Age 18-80 years old
  • Female and male patients
  • At least 1 risk factor for aspiration of gastric contents
  • Preoperative fasting period less than 6 hours
Key exclusion· 11
  • Predicted impossible tracheal intubation based on airway assessment criteria
  • Preoperative arterial hypotension (MAP < 65 mmHg or under catecholamine)
  • Preoperative respiratory distress syndrome (SpO2 < 90% in room air)
  • Allergy to ketamine, propofol, NMB, soy, or peanuts

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06733129
NCT06733129Phase 3RecruitingOn TrackUpdated 6mo ago

Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room: a 3-arm Randomized Trial

Nantes University Hospital·interventional·Posted Dec 13, 2024·Updated Dec 2, 2025

In Brief

A Phase 3 clinical trial evaluating direct IV injection and combination of Ketamine and Propofol for Rapid Sequence Induction. Currently recruiting, targeting 1,218 participants across 20 sites.

Detailed Summary

The best hypnotic choice to optimize the balance between good intubation condition quality and hemodynamic stability during RSI performed in the operating theatre remained to be investigated. Therefore, a randomized study evaluating the efficacy of propofol, ketamine, and a combination of both is appropriate. So, we designed the HyPnotiKs randomized controlled study to investigate the efficacy of these hypnotic drugs in patients undergoing RSI in the operating theatre. The primary endpoint will be the successful tracheal intubation at the first attempt without major arterial hypotension event.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

Phase 3Recruiting
202520262027
First PostedDec 13, 2024
Enrollment StartApr 14, 2025
Primary CompletionApr 14, 2027
Study CompletionApr 30, 2027
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 1.6 years agoPrimary completion in 9 months

Interventions

direct IV injectiondrug

direct IV injection at dosage of 2 mg/kg (adjusted body weight if BMI \> 30) after completing pre-oxygenation

combination of Ketamine and Propofoldrug

combination of Ketamine and Propofol described above: consecutive direct IV injection of Ketamine 1 mg/kg and Propofol 1 mg/kg (adjusted body weight if BMI \> 30). Dilution are not necessary.